ROTTERDAM, The Netherlands, March 12 -- A bioabsorbable, drug-eluting stent appears to be safe and effective for treating de novo coronary artery lesions, according to results from the open-label ABSORB study.
ROTTERDAM, The Netherlands, March 12 -- A bioabsorbable, drug-eluting stent appears to be safe and effective for treating de novo coronary artery lesions, according to results from the open-label ABSORB study.
